These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33147357)

  • 1. How does the gut microbiome influence immune checkpoint blockade therapy?
    Almonte AA; Rangarajan H; Yip D; Fahrer AM
    Immunol Cell Biol; 2021 Apr; 99(4):361-372. PubMed ID: 33147357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
    Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
    Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review.
    Halsey T; Ologun G; Wargo J; Jenq RR
    Semin Hematol; 2020 Jan; 57(1):13-18. PubMed ID: 32690139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in research on the relationship between the gut microbiome and cancer.
    Song P; Wang QB; Liang B; Jiang SJ
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5104-5112. PubMed ID: 34486684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome modulates efficacy of immune checkpoint inhibitors.
    Yi M; Yu S; Qin S; Liu Q; Xu H; Zhao W; Chu Q; Wu K
    J Hematol Oncol; 2018 Mar; 11(1):47. PubMed ID: 29580257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome and cancer immunotherapy.
    Sun JY; Yin TL; Zhou J; Xu J; Lu XJ
    J Cell Physiol; 2020 May; 235(5):4082-4088. PubMed ID: 31663125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the sex hormone-gut microbiome axis in tumor immunotherapy.
    Wang L; Tang L; Zhai D; Song M; Li W; Xu S; Jiang S; Meng H; Liang J; Wang Y; Zhang B
    Gut Microbes; 2023; 15(1):2185035. PubMed ID: 36880651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer.
    Chen Y; Lai X
    Math Biosci; 2022 Aug; 350():108868. PubMed ID: 35753521
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tomita Y; Goto Y; Sakata S; Imamura K; Minemura A; Oka K; Hayashi A; Jodai T; Akaike K; Anai M; Hamada S; Iyama S; Saruwatari K; Saeki S; Takahashi M; Ikeda T; Sakagami T
    Oncoimmunology; 2022; 11(1):2081010. PubMed ID: 35655708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
    Wang J; Zhu N; Su X; Yang R
    Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tracking Research Progress in the Modulatory Role of Gut Microbiome in Immune Checkpoint Inhibitors Applied in Cancer Treatment].
    Wu MR; Tang MY; Zheng BH; Zhou ST
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Sep; 52(5):735-739. PubMed ID: 34622585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between Immunotherapy with Immune Checkpoint Inhibitors(Anti-PD-1 Antibodies)and Intestinal Microbiota].
    Ozaki Y; Suzuki Y; Nishiyama K; Suzutani T; Suzuki H
    Gan To Kagaku Ryoho; 2021 Sep; 48(9):1096-1099. PubMed ID: 34521783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy.
    Davar D; Zarour HM
    Clin Cancer Res; 2022 Oct; 28(20):4370-4384. PubMed ID: 35748749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not？.
    Xiaoyu P; Chao G; Lihua D; Pengyu C
    Gut Microbes; 2020 Jul; 11(4):691-705. PubMed ID: 32216675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut microbiota and immune checkpoint inhibitors.
    Humphries A; Daud A
    Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer.
    Temraz S; Nassar F; Nasr R; Charafeddine M; Mukherji D; Shamseddine A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.